Ligand validation:7VFL

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 7VFL designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7VFL_NAG_C_602	56%	68%	0.156	0.93	0.48	0.72	-	-	0	0	100%	1
7VFL_NAG_D_100	53%	57%	0.175	0.937	0.9	0.76	1	-	0	1	100%	0.9333
7VFL_NAG_A_602	23%	69%	0.235	0.859	0.47	0.68	-	-	0	0	100%	1
7VFL_NAG_D_101	19%	49%	0.282	0.878	0.77	1.18	-	2	0	1	100%	0.9333
7VFL_NAG_G_101	7%	45%	0.36	0.821	0.77	1.38	-	3	0	1	100%	0.9333
7EC3_NAG_D_100	48%	9%	0.187	0.93	1.9	2.75	1	7	1	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.